SIRT7 and melanoma: We treated TM-stimulated melanoma cells with NF-κB p65 inhibitor APDC, and the up-regulation of SIRT7 was prominently impaired (Fig. S10c, d), raising the notion that NF-κB p65 also contributed to SIRT7 up-regulation under stress.